KELSEY REA: Open Payments
NPI 1548817000 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,855 in 78 payments from 19 companies in 2025. Trend: 2023 $2,503 · 2024 $2,735 · 2025 $1,855
Food & beverage: $1,855
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $314 |
| Ascendis Pharma Endocrinology Inc | 3 | $237 |
| Janssen Biotech, Inc. | 10 | $226 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $190 |
| Ardelyx, Inc. | 4 | $88 |
| GENZYME CORPORATION | 3 | $87 |
| Ipsen Biopharmaceuticals, Inc | 3 | $85 |
| Phathom Pharmaceuticals, Inc. | 3 | $75 |
| Aimmune Therapeutics, Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $70 |
Products named: Yorvipath, TREMFYA, XIFAXAN, DUPIXENT, LINZESS, RINVOQ, IBSRELA, IQIRVO.
Industry payments across NC — which companies pay providers there.
